cdmo.directory
← Compare landing

Biomay AG vs eXmoor Pharma

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/biomay/exmoorpharma

CategoryBiomay AGeXmoor Pharma
Listed sitecdmocdmo
SummaryGMP CDMO specializing in plasmid DNA, mRNA, and recombinant protein manufacturing from gene construction to market supply, with in-house mRNA lipid-nanoparticle formulation and aseptic fill-finish capabilities.Integrated cell and gene therapy CDMO with 20+ years of consultancy expertise, offering end-to-end CMC support from early-phase strategy through GMP manufacturing across viral vectors, autologous/allogeneic cell therapies, and RNA technologies.
Services
  • mRNA Manufacturing
  • Cell-Line Development
  • Recombinant Protein Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Lipid Nanoparticle (LNP) Formulation
  • Process Development
  • CMC Analytical Development
  • CMC Regulatory Submission Support
  • CMC Regulatory Submission Support
  • CMC Analytical Development
  • Process Development
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Cell Therapy Manufacturing
  • Viral Vector Manufacturing
  • mRNA Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
Modalities
  • mRNA
  • Gene Therapy
  • Cell Therapy
  • Gene Therapy
  • mRNA
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters, Vienna, Austria
  • Headquarters
Certifications
  • EMA · Identifier: GMP
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.